Name | Number of supported studies | Average coverage | |
---|---|---|---|
smooth muscle cell | 7 studies | 32% ± 14% | |
fibroblast | 7 studies | 26% ± 9% | |
pericyte | 6 studies | 19% ± 2% | |
endothelial cell | 5 studies | 25% ± 7% | |
myofibroblast cell | 5 studies | 20% ± 3% | |
connective tissue cell | 5 studies | 22% ± 6% | |
ciliated cell | 5 studies | 23% ± 5% | |
pancreatic A cell | 3 studies | 27% ± 5% | |
epithelial cell | 3 studies | 34% ± 14% | |
GABAergic neuron | 3 studies | 24% ± 5% | |
glutamatergic neuron | 3 studies | 35% ± 11% | |
oligodendrocyte precursor cell | 3 studies | 21% ± 3% | |
luminal hormone-sensing cell of mammary gland | 3 studies | 17% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 8968.28 | 180 / 180 | 100% | 29.62 | 430 / 430 |
prostate | 100% | 3595.20 | 244 / 245 | 100% | 59.35 | 502 / 502 |
adrenal gland | 100% | 2772.59 | 258 / 258 | 99% | 79.56 | 228 / 230 |
thymus | 100% | 1567.93 | 651 / 653 | 99% | 43.42 | 600 / 605 |
breast | 100% | 1955.61 | 458 / 459 | 99% | 74.67 | 1106 / 1118 |
brain | 98% | 1950.54 | 2593 / 2642 | 100% | 62.98 | 705 / 705 |
bladder | 100% | 5125.00 | 21 / 21 | 98% | 32.37 | 492 / 504 |
lung | 99% | 1693.96 | 572 / 578 | 98% | 24.96 | 1132 / 1155 |
uterus | 99% | 7582.46 | 169 / 170 | 97% | 33.16 | 445 / 459 |
kidney | 99% | 1200.90 | 88 / 89 | 97% | 26.93 | 876 / 901 |
intestine | 99% | 2349.21 | 960 / 966 | 97% | 25.79 | 509 / 527 |
stomach | 97% | 1810.49 | 350 / 359 | 95% | 23.53 | 273 / 286 |
skin | 94% | 955.40 | 1695 / 1809 | 94% | 24.36 | 446 / 472 |
esophagus | 96% | 3189.05 | 1383 / 1445 | 89% | 15.47 | 163 / 183 |
pancreas | 72% | 519.50 | 236 / 328 | 99% | 29.04 | 176 / 178 |
liver | 60% | 400.38 | 136 / 226 | 94% | 20.29 | 381 / 406 |
blood vessel | 100% | 4819.27 | 1335 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 16.41 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 13.70 | 1 / 1 |
spleen | 100% | 1408.75 | 240 / 241 | 0% | 0 | 0 / 0 |
adipose | 99% | 1725.24 | 1197 / 1204 | 0% | 0 | 0 / 0 |
muscle | 99% | 1548.77 | 798 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 22.62 | 73 / 80 |
heart | 90% | 1004.64 | 774 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 15.44 | 25 / 29 |
peripheral blood | 19% | 173.04 | 174 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | TCEAL1 |
Protein name | Transcription elongation factor A protein-like 1 (TCEA-like protein 1) (Nuclear phosphoprotein p21/SIIR) (Transcription elongation factor S-II protein-like 1) |
Synonyms | SIIR |
Description | FUNCTION: May be involved in transcriptional regulation. Modulates various viral and cellular promoters in a promoter context-dependent manner. For example, transcription from the FOS promoter is increased, while Rous sarcoma virus (RSV) long terminal repeat (LTR) promoter activity is repressed. Does not bind DNA directly. |
Accessions | ENST00000372624.3 ENST00000372625.8 Q15170 ENST00000372626.7 |